Inventor
TOPALOV GEORGE T
US21 patents
⚠️ This page may combine multiple inventors who share the name “TOPALOV GEORGE T”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
KNOPP BIOSCIENCES LLC
10 patentsUS9914708B2Mar 13, 2018
Benzoimidazol-1,2-yl amides as Kv7 channel activators
KNOPP BIOSCIENCES LLC10 citations92
US9481653B2Nov 1, 2016
Benzoimidazol-1,2-yl amides as Kv7 channel activators
KNOPP BIOSCIENCES LLC15 citations92
US11724990B2Aug 15, 2023
Kv7 channel activators compositions and methods of use
KNOPP BIOSCIENCES LLC4 citations85
US10851067B2Dec 1, 2020
Kv7 channel activators compositions and methods of use
KNOPP BIOSCIENCES LLC6 citations83
US10385025B2Aug 20, 2019
Benzoimidazol-1,2-yl amides as Kv7 channel activators
KNOPP BIOSCIENCES LLC9 citations83
US10106536B2Oct 23, 2018
Imidazo(4,5-B) pyridin-2-yl amides as KV7 channel activators
KNOPP BIOSCIENCES LLC5 citations83
US9650376B2May 16, 2017
Imidazo(4,5-B) pyridin-2-yl amides as KV7 channel activators
KNOPP BIOSCIENCES LLC8 citations81
US11261162B2Mar 1, 2022
KV7 channel activators compositions and methods of use
KNOPP BIOSCIENCES LLC3 citations72
US10906877B2Feb 2, 2021
Benzoimidazol-1,2-yl amides as Kv7 channel activators
KNOPP BIOSCIENCES LLC1 citations72
US10526328B2Jan 7, 2020
Imidazo[4,5-b]pyridin-2-yl amides as Kv7 channel activators
KNOPP BIOSCIENCES LLC0 citations51
BIOHAVEN THERAPEUTICS LTD
3 patentsUS12351559B2Jul 8, 2025
Benzoimidazol benzomidazol-1,2-yl amides as Kv7 channel activators
BIOHAVEN THERAPEUTICS LTD0 citations62
US12286408B2Apr 29, 2025
KV7 channel activators compositions and methods of use
BIOHAVEN THERAPEUTICS LTD0 citations62
US11834418B2Dec 5, 2023
Benzoimidazol-1,2-yl amides as Kv7 channel activators
BIOHAVEN THERAPEUTICS LTD0 citations62
ARRAY BIOPHARMA INC
3 patentsUS9809590B2Nov 7, 2017
Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors
ARRAY BIOPHARMA INC1 citations61
US10669269B2Jun 2, 2020
Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors
ARRAY BIOPHARMA INC0 citations49
US8987251B2Mar 24, 2015
Triazolopyridine compounds as PIM kinase inhibitors
ARRAY BIOPHARMA INC0 citations36
ALLEN SHELLEY
2 patentsBOYS MARK LAURENCE
2 patentsUS9174981B2Nov 3, 2015
Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors
BOYS MARK LAURENCE3 citations58
US8841455B2Sep 23, 2014
Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as cFMS inhibitors
BOYS MARK LAURENCE1 citations46